Related Experiment Video
Updated: Jul 13, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Pulmonary infections in patients with rheumatoid arthritis]
Noboru Takayanagi1, Yutaka Tsuchiya, Daidou Tokunaga
1Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center.
Abstract:
We studied 149 rheumatoid arthritis (RA) patients (mean age 68.0 years; 68 men, 81 women) with pulmonary infections. The mean age at the onset of RA and the duration of RA was 57.2 +/- 15.2 years and 10.9 +/- 11.5 years, respectively. Pulmonary infections included nontuberculous mycobacteriosis in 59 patients (Mycobacterium avium complex infection, 50 cases : Mycobacterium kansasii infection, 4 cases; others, 5 cases), pneumonia in 46 patients, pulmonary tuberculosis in 28 patients, pulmonary aspergillosis in 12 patients, pulmonary cryptococcosis in 5 patients, Pneumocystis jiroveci pneumonia in 5 patients, lung abscess in 9 patients, exacerbation of bronchiectasis in 7 patients, and empyema in 4 patients. One hundred percent of patients with exacerbation of bronchiectasis, 91.7% of patients with pulmonary aspergillosis, 87% of patients with pneumonia, and 81.4% of patients with nontuberculous mycobacteriosis had underlying lung diseases. The pulmonary infections during therapy with steroids were pulmonary tuberculosis (78.6%), pneumonia (65.2%), and pulmonary aspergillosis (58.3%), while the pulmonary infections during methotrexate treatment were Pneumocystis jiroveci pneumonia (80%), pulmonary cryptococcosis (40%), and pulmonary tuberculosis (28.6%). Pulmonary infections in RA patients who were taking TNFalpha inhibitors included 1 patient each with nontuberculous mycobacteriosis, pneumonia, pulmonary tuberculosis, and Pneumocystis jiroveci pneumonia. Among the RA patients with lung abscess, malignancy was noted in 55.6%, and diabetes mellitus in 22.2%. Pseudomonas aeruginosa was the second-most-common cause of pneumonia and cause of all exacerbations of bronchiectasis. As well as immunosuppressive medications (steroids, methotrexate, TNFalpha inhibitors) and systemic comorbid diseases, underlying lung diseases could be one of the risk factor for pulmonary infections in patients with RA. The dominant risk factor for each pulmonary infection in patients with RA might be different.
Insights
Rheumatoid arthritis patients face diverse pulmonary infections, including nontuberculous mycobacteriosis and pneumonia. Underlying lung disease and immunosuppressive therapies are key risk factors for these infections.
Area of Science:
- Rheumatology
- Infectious Diseases
- Pulmonology
Context:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting joints and potentially other organs.
- Pulmonary complications are a significant cause of morbidity and mortality in RA patients.
- Understanding the spectrum and risk factors of pulmonary infections in RA is crucial for patient management.
Purpose:
- To investigate the types and prevalence of pulmonary infections in rheumatoid arthritis patients.
- To identify underlying conditions and treatments associated with increased risk of pulmonary infections in RA.
- To analyze the specific risk factors contributing to different types of pulmonary infections in this population.
Summary:
- A study of 149 RA patients revealed various pulmonary infections, with nontuberculous mycobacteriosis (59 cases) and pneumonia (46 cases) being most common.
- Underlying lung diseases were prevalent, especially in patients with exacerbation of bronchiectasis (100%), pulmonary aspergillosis (91.7%), and pneumonia (87%).
- Immunosuppressive therapies like steroids, methotrexate, and TNFalpha inhibitors were associated with specific infections, while comorbidities like malignancy and diabetes mellitus were noted in lung abscess cases. Pseudomonas aeruginosa was a common pathogen.
Impact:
- This research highlights the complex interplay of factors contributing to pulmonary infections in RA patients.
- It underscores the importance of considering underlying lung disease, specific immunosuppressive treatments, and comorbidities when assessing infection risk.
- Findings can inform clinical practice, leading to better diagnostic strategies and preventative measures for pulmonary infections in rheumatoid arthritis.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Rheumatic Heart Disease I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment
Other Pulmonary Disorders
